Answers are grounded in this paper and cite their sources.
In the Swiss HIV Cohort Study, 61 of 222 (27%) HIV-suppressed persons with chronic hepatitis B virus (HBV) infection had HBV replication after 2 years on tenofovir, of whom 77% were suppressed thereafter. Self-reported adherence to therapy and HBV viral load at tenofovir initiation were predictors of persistent replication.
No takes yet. Share an insight, caveat, or question.
Hofmann et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: